[Eprazinone exanthema with subcorneal pustulosis].
A drug eruption with subcorneal pustulation is presented, occurring in a patient during treatment with eprazinone . The biopsy of the initial lesions showed changes as in pustulosis subcornealis . The aetiopathogenetic relationship between administration of eprazinone and the pustular eruption was confirmed by patch test.
D005076:Exanthema / Q000139:chemically induced* / Q000473:pathology; D005100:Expectorants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011427:Propiophenones / Q000009:adverse effects*
D005100:Expectorants; D011427:Propiophenones; C007608:eprazinone
Eprazinonexanthem mit subkornealer Pustelbildung.